Search for stocks /

Zydus Wellness Ltd Q2FY26 – Sugar-Free Profits, Full-Fat Borrowings, and a Double Dose of Acquisitions


1. At a Glance

If FMCG was a college, Zydus Wellness would be that health-conscious nerd who aces nutrition class but somehow keeps borrowing lunch money. At a market cap of ₹14,731 crore and a current price of ₹463 (as of Nov 4, 2025), the company looks toned on the outside, but the financial BMI says “slightly bloated.”

The last quarter (Q2 FY26) was a mixed gym session — revenues flexed 31% YoY to ₹6,429 million (₹643 crore), thanks to new protein bars and glucose drinks pumping up sales. But profit after tax stumbled to a loss of ₹52.8 crore, a 257% dive from the same quarter last year. Ouch. Operating profit margin? Down to 4% — about as thin as sugar-free syrup.

Still, the stock has run 19.8% in three months, 34.3% in six, because apparently, the market enjoys a bit of drama with its protein shakes. ROE is 6.02%, P/E a hefty 52.3x — the valuation equivalent of paying premium gym fees for a yoga mat.

So, what’s cooking? Acquisitions galore — ₹3,900 crore for Naturell India (makers of RiteBite Max Protein) and a £239 million deal for UK-based Comfort Click. Add to that a ₹56.33 crore GST demand (courtesy DGGI Surat), and the quarter was basically Zydus’ version of a Bollywood fitness montage — sweat, shocks, and a happy ending in sight.


2. Introduction

Zydus Wellness Limited isn’t just selling health — it’s selling aspiration. This is the company behind every middle-class Indian who wants to feel guilt-free while eating mithai made with Sugar-Free Gold, who puts Everyuth peel-off mask before a Zoom call, and who’s probably chugging Glucon-D after two flights of stairs.

Born from the DNA of pharma giant Zydus Lifesciences, the company’s journey has been like a diet plan — occasional bursts of progress followed by cheat days (read: debt, acquisitions, and tax issues). The wellness empire spans categories from nutrition (Complan, Glucon-D, Sugar-Free) to personal care (Everyuth, Nycil) to spreads (Nutralite). Basically, it’s a mini-Unilever but with more vitamins and fewer colas.

However, FY26 began with a bang — literally buying health at scale. The Naturell India acquisition (₹3,900 crore) in October 2024 brought them Max Protein bars, cookies, and chips. Then came Comfort Click UK (GBP 239 million) in August 2025, adding vitamins and minerals from Europe to Zydus’s pantry.

But here’s the twist — all this wellness expansion was funded fully by cash and debt, leading to borrowings ballooning to ₹3,042 crore as of Sep 2025. The once “asset-light” FMCG model now carries more load than a bodybuilder’s protein bag.

And yet, Zydus Wellness soldiers on — with 93.9% market share in sugar substitutes, 59.4% in glucose powder, and 46% in face scrubs. When it comes to dominating small corners of big markets, this company’s got six-pack abs.


3. Business Model – WTF Do They Even Do?

Imagine a company where Sugar-Free, Everyuth, Complan, Glucon-D, Nycil, and Nutralite all share the same fridge. That’s Zydus Wellness.

Their game plan is simple: make you feel good and look good, sometimes in the same breath.

Segment 1 – Food & Nutrition:
Home to Complan (for kids and adults), Glucon-D (for heatstroke survivors), Sugar-Free (for diabetic uncles), and Nutralite (for cholesterol warriors). Basically, everything your mom nags you to eat.

Segment 2 – Personal Care:
Under Everyuth (scrubs, face masks, cleansers) and Nycil (prickly heat powder) — the brand portfolio that makes summers survivable and teenagers tolerable.

New Toys – Naturell & Comfort Click:
The newly acquired Naturell India brings health bars and protein snacks under RiteBite Max Protein. Meanwhile, Comfort Click (UK) adds vitamins, minerals, and supplements (VMS) — a market Zydus now enters like a gym bro entering GNC.

E-commerce now forms 12.5% of total sales, up from 4% in FY21 — a strong sign of modern retail muscle.

Their distribution network spans 1,700+ distributors and ~2,000 on-ground reps backed by 24 warehouses. If FMCG distribution were a marathon, Zydus just booked the hydration station.


4. Financials Overview

Let’s look at the numbers where “healthy lifestyle” meets “financial cholesterol.”

Metric (₹ Cr)Latest Qtr (Sep’25)YoY Qtr (Sep’24)Prev Qtr (Jun’25)YoY %QoQ %
Revenue650493861+31.9%-24.5%
EBITDA2320156+15.0%-85.3%
PAT-52.821128-357%-141%
EPS (₹)-1.660.664.02-352%-141%

Commentary:
If Q2FY26 was a body, revenue hit the treadmill hard, but profits fainted mid-sprint. Despite the 32% jump in sales, profits plunged due to integration costs, acquisition

Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!